Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Alessa Pardo"'
Autor:
Mehmet Kemal Tur, Stefan Barth, Alessa Pardo, Claudia Kessler, Rainer Fischer, Stefan Gattenlöhner, Katharina Kolberg
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 143:2025-2038
Despite great progress in the diagnosis and treatment of localized prostate cancer (PCa), there remains a need for new diagnostic markers that can accurately distinguish indolent and aggressive variants. One promising approach is the antibody-based t
Autor:
Rama Shanker Verma, Janendra K. Batra, Stefan Barth, Reinhard Rosinke, Alessa Pardo, Swati Choudhary
Publikováno v:
Applied Microbiology and Biotechnology. 100:263-277
Autocrine activation of c-kit (KIT receptor tyrosine kinase) has been postulated to be a potent oncogenic driver in small cell lung cancer, neuroblastoma (NB), and poorly differentiated colorectal carcinoma (CRC). Although targeted therapy involving
Autor:
Hannes Brehm, Rainer Fischer, Stefan Barth, Dmitrij Hristodorov, Judith Niesen, Alessa Pardo, Radoslav Mladenov, Mehmet Kemal Tur
Publikováno v:
Cancer Letters. 365:149-155
The treatment of rhabdomyosarcoma (RMS) is challenging, and the prognosis remains especially poor for high-grade RMS with metastasis. The conventional treatment of RMS is based on multi-agent chemotherapy combined with resection and radiotherapy, whi
Autor:
Theophilus Thepen, Alessa Pardo, Stefan Barth, Radoslav Mladenov, Michael Huhn, Rainer Fischer, Dmitrij Hristodorov, Anh-Tuan Pham
Publikováno v:
British Journal of Cancer
Background: Antibody drug conjugates (ADCs) and immunotoxins (ITs) are promising anticancer immunotherapeutics. Despite their encouraging performance in clinical trials, both ADCs and ITs often suffer from disadvantages such as stoichiometrically und
Publikováno v:
Current Pharmaceutical Design. 19:5406-5413
Over the past few years, the SNAP-tag technology has become a methodology with great potential in a variety of applications, e.g. the (specific) visualization of individual proteins and studies of protein interaction in living cells. Furthermore, the
Autor:
Thomas Nachreiner, Fabian Kiessling, Alessa Pardo, Dmitrij Hristodorov, Anh-Tuan Pham, Theophilus Thepen, Manal Amoury, Wijnand Helfrich, Katharina Kolberg, Stefano Di Fiore, Stefan Barth, Ahmad Fawzi Hussain, Rainer Fischer, Radoslav Mladenov
Publikováno v:
Cancer letters, 372(2), 201-209. ELSEVIER IRELAND LTD
Triple-negative breast cancer (TNBC) is associated with poor prognosis and high prevalence among young premenopausal women. Unlike in other breast cancer subtypes, no targeted therapy is currently available. Overexpression of epithelial cell adhesion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31d6859673fec3065cf7cb6d0350d578
https://research.rug.nl/en/publications/2e9958d4-de01-40bb-b2af-2caf41a6a400
https://research.rug.nl/en/publications/2e9958d4-de01-40bb-b2af-2caf41a6a400
Autor:
Rainer Fischer, Michael Stöcker, Alessa Pardo, Theo Thepen, Florian Kampmeier, Georg Melmer, Stefan Barth
Publikováno v:
Cancer Immunology, Immunotherapy. 61:1617-1626
Preclinical in vivo analyses of treatment responses are an important prerequisite to evaluate new therapeutics. Molecular in vivo imaging in the far red (FR)/near infra red (NIR) is a promising method, as it enables measurements at different time poi
Autor:
Chris P. M. Reutelingsperger, Rainer Fischer, Christian Hetzel, Alessa Pardo, Stefan Barth, Michael Stöcker
Publikováno v:
Protein Expression and Purification. 58:325-331
The Ca2+-dependent binding of annexin A5 to phosphatidylserine on cell surfaces is a reliable marker for apoptosis that is widely used in flow cytometry based apoptosis assays. In this approach, annexin A5 must be coupled to a fluorescent dye, but st
Autor:
Manal, Amoury, Radoslav, Mladenov, Thomas, Nachreiner, Anh-Tuan, Pham, Dmitrij, Hristodorov, Stefano, Di Fiore, Wijnand, Helfrich, Alessa, Pardo, Georg, Fey, Michael, Schwenkert, Theophilus, Thepen, Fabian, Kiessling, Ahmad F, Hussain, Rainer, Fischer, Katharina, Kolberg, Stefan, Barth
Publikováno v:
International journal of cancer. 139(4)
Chondroitin sulfate proteoglycan 4 (CSPG4) has been identified as a highly promising target antigen for immunotherapy of triple-negative breast cancer (TNBC). TNBC represents a highly aggressive heterogeneous group of tumors lacking expression of est
Autor:
Wijnand Helfrich, Rainer Fischer, Judith Niesen, Stefan Barth, Hannes Brehm, Georg H. Fey, Radoslav Mladenov, Christoph Stein, Stefan Gattenlöhner, Alessa Pardo
Publikováno v:
Cancer letters, 352(2), 228-235. ELSEVIER IRELAND LTD
The treatment of rhabdomyosarcoma (RMS) remains challenging, with metastatic and alveolar RMS offering a particularly poor prognosis. Therefore, the identification and evaluation of novel antigens, which are suitable targets for immunotherapy, is one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2799ea3b1b751eb8479f2554a5941abe
https://research.rug.nl/en/publications/787d4fff-4fbe-4c6e-b1ec-9b8e2a0edc39
https://research.rug.nl/en/publications/787d4fff-4fbe-4c6e-b1ec-9b8e2a0edc39